Noxopharm Limited
Boris brings comprehensive market knowledge, thorough research and years of experience in investment markets & Business Consulting.
Boris’s experience lends itself to Financial & Investment advising but also as a business consultant to further enhance business opportunities in Medical technology & in sourcing other opportunities to enhance investments. Boris has worked extensively with Israeli companies to explore various opportunities in the Medical & disruptive technology space.
Boris has developed an in-depth understanding of industry trends and gained valuable insight into domestic and international markets. Boris has specialised in reconstruction of Companies, Investments &International trade
Boris has completed a Bachelor of Science (Industrial Chemistry). Currently a member of MeSAFAA & an AR with Morgans Financial Ltd.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Noxopharm Limited
Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company.